{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T09:05:41Z","timestamp":1776157541637,"version":"3.50.1"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"the National Key R&D Program of China","award":["2024YFC3506100"],"award-info":[{"award-number":["2024YFC3506100"]}]},{"name":"the Research Project of Zhejiang Chinese Medical University","award":["2025JKZKTS01"],"award-info":[{"award-number":["2025JKZKTS01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease involving immune dysregulation, metabolic reprogramming, and multi-organ damage. The Jieduquyuziyin prescription (JP), a contemporary Chinese herbal formula based on the Traditional Chinese Medicine principle of \u201cJiedu Quyu Ziyin,\u201d has shown clinical efficacy in SLE. This review aims to synthesize clinical and preclinical evidence explaining how JP achieves systemic therapeutic effects by targeting interconnected pathological pathways in SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We systematically searched PubMed, Web of Science, and CNKI (January 1999\u2013December 2025) for clinical trials, preclinical studies, and multi-omics analyses investigating JP or its bioactive compounds in SLE.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Clinical evidence demonstrates that JP-containing regimens significantly reduce SLEDAI scores, alleviate lupus nephritis, lower glucocorticoid requirements, and improve quality of life in SLE patients. Preclinical studies in SLE-prone MRL\/lpr mice reveal that JP targets key SLE pathogenic pathways: it restores Th17\/Treg balance, suppresses SLE-associated pathogenic B cell proliferation via AKT\/mTOR inhibition, and promotes apoptosis of double-negative T cells through UBE2M-mediated Bim upregulation. JP inhibits macrophage IRAK1\/ NF-\u03baB signaling, attenuates lupus nephritis by activating renal FXR to suppress TGF-\u03b21\/\u03b1-SMA-driven fibrosis, and mitigates oxidative damage via Nrf2 activation. Addressing SLE-associated immunometabolic dysfunction, JP reverses pathological glycolytic reprogramming in lymphocytes via AMPK signaling and restores mitochondrial function. Additionally, JP remodels gut microbiota in SLE models, enriching Akkermansia and modulating short-chain fatty acid and bile acid metabolism to reinforce immune homeostasis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This review validates JP as a system-level therapeutic strategy targeting immune dysregulation, metabolic reprogramming, and gut dysbiosis in SLE, supporting the TCM principle of \u201cJiedu Quyu Ziyin\u201d and its integration with modern immunology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Graphical abstract<\/jats:title>\n                  <\/jats:sec>","DOI":"10.1186\/s13020-026-01397-x","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:14:05Z","timestamp":1776154445000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Jieduquyuziyin prescription for systemic lupus erythematosus: a system-level therapeutic strategy for immunological recalibration"],"prefix":"10.1186","volume":"21","author":[{"given":"Yihong","family":"Gan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingqun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shihui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ke","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongsheng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"1397_CR1","doi-asserted-by":"publisher","first-page":"ITC81","DOI":"10.7326\/AITC202006020","volume":"172","author":"M Kiriakidou","year":"2020","unstructured":"Kiriakidou M, Ching CL. Systemic lupus erythematosus. Ann Intern Med. 2020;172:ITC81-96. https:\/\/doi.org\/10.7326\/AITC202006020.","journal-title":"Ann Intern Med"},{"key":"1397_CR2","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/art.40479","volume":"70","author":"LE Cheng","year":"2018","unstructured":"Cheng LE, Amoura Z, Cheah B, Hiepe F, Sullivan BA, Zhou L, et al. Brief report: a randomized, double\u2010blind, parallel\u2010group, placebo\u2010controlled, multiple\u2010dose study to evaluate AMG 557 in patients with systemic lupus erythematosus and active lupus arthritis. Arth Rheumatol. 2018;70:1071\u20136. https:\/\/doi.org\/10.1002\/art.40479.","journal-title":"Arth Rheumatol"},{"key":"1397_CR3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.clindermatol.2006.07.014","volume":"24","author":"N Rothfield","year":"2006","unstructured":"Rothfield N, Sontheimer RD, Bernstein M. Lupus erythematosus: systemic and cutaneous manifestations. Clin Dermatol. 2006;24:348\u201362. https:\/\/doi.org\/10.1016\/j.clindermatol.2006.07.014.","journal-title":"Clin Dermatol"},{"key":"1397_CR4","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1001\/jama.2024.2315","volume":"331","author":"CH Siegel","year":"2024","unstructured":"Siegel CH, Sammaritano LR. Systemic lupus erythematosus: a review. JAMA. 2024;331:1480\u201391. https:\/\/doi.org\/10.1001\/jama.2024.2315.","journal-title":"JAMA"},{"key":"1397_CR5","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41584-018-0156-8","volume":"15","author":"N Schwartz","year":"2019","unstructured":"Schwartz N, Stock AD, Putterman C. Neuropsychiatric lupus: new mechanistic insights and future treatment directions. Nat Rev Rheumatol. 2019;15:137\u201352. https:\/\/doi.org\/10.1038\/s41584-018-0156-8.","journal-title":"Nat Rev Rheumatol"},{"key":"1397_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41581-023-00797-8","volume":"20","author":"WG Ambler","year":"2024","unstructured":"Ambler WG, Kaplan MJ. Vascular damage in systemic lupus erythematosus. Nat Rev Nephrol. 2024;20:251\u201365. https:\/\/doi.org\/10.1038\/s41581-023-00797-8.","journal-title":"Nat Rev Nephrol"},{"key":"1397_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00611","volume":"9","author":"V Rider","year":"2018","unstructured":"Rider V, Abdou NI, Kimler BF, Lu N, Brown S, Fridley BL. Gender bias in human systemic lupus erythematosus: A problem of steroid receptor action? Front Immunol. 2018;9:611. https:\/\/doi.org\/10.3389\/fimmu.2018.00611.","journal-title":"Front Immunol"},{"key":"1397_CR8","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.molmed.2020.09.009","volume":"27","author":"ME Allen","year":"2021","unstructured":"Allen ME, Rus V, Szeto GL. Leveraging heterogeneity in systemic lupus erythematosus for new therapies. Trends Mol Med. 2021;27:152\u201371. https:\/\/doi.org\/10.1016\/j.molmed.2020.09.009.","journal-title":"Trends Mol Med"},{"key":"1397_CR9","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1038\/nrrheum.2016.186","volume":"12","author":"GC Tsokos","year":"2016","unstructured":"Tsokos GC, Lo MS, Reis PC, Sullivan KE. New insights into the immunopathogenesis of systemic Lupus Erythematosus. Nat Rev Rheumatol. 2016;12:716\u201330. https:\/\/doi.org\/10.1038\/nrrheum.2016.186.","journal-title":"Nat Rev Rheumatol"},{"key":"1397_CR10","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","volume":"20","author":"WH Robinson","year":"2024","unstructured":"Robinson WH, Younis S, Love ZZ, Steinman L, Lanz TV. Epstein-Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol. 2024;20:729\u201340. https:\/\/doi.org\/10.1038\/s41584-024-01167-9.","journal-title":"Nat Rev Rheumatol"},{"key":"1397_CR11","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1002\/art.41787","volume":"73","author":"SA Ramanujan","year":"2021","unstructured":"Ramanujan SA, Cravens EN, Krishfield SM, Kyttaris VC, Moulton VR. Estrogen-induced hsa-miR-10b-5p is elevated in T cells from patients with systemic lupus erythematosus and down-regulates serine\/arginine-rich splicing factor 1. Arthritis Rheumatol. 2021;73:2052\u20138. https:\/\/doi.org\/10.1002\/art.41787.","journal-title":"Arthritis Rheumatol"},{"key":"1397_CR12","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/art.20049","volume":"50","author":"KH Costenbader","year":"2004","unstructured":"Costenbader KH, Kim DJ, Peerzada J, Lockman S, Nobles-Knight D, Petri M, et al. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arth Rheum. 2004;50:849\u201357. https:\/\/doi.org\/10.1002\/art.20049.","journal-title":"Arth Rheum"},{"key":"1397_CR13","first-page":"265","volume":"19","author":"M Petri","year":"1992","unstructured":"Petri M, Allbritton J. Antibiotic allergy in systemic lupus erythematosus: a case-control study. J Rheumatol. 1992;19:265\u20139.","journal-title":"J Rheumatol"},{"key":"1397_CR14","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.immuni.2020.04.015","volume":"52","author":"C Soni","year":"2020","unstructured":"Soni C, Perez OA, Voss WN, Pucella JN, Serpas L, Mehl J, et al. Plasmacytoid dendritic cells and type I interferon promote extrafollicular B cell responses to extracellular self-DNA. Immunity. 2020;52:1022-1038.e7. https:\/\/doi.org\/10.1016\/j.immuni.2020.04.015.","journal-title":"Immunity"},{"key":"1397_CR15","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41584-024-01210-9","volume":"21","author":"M Stockfelt","year":"2025","unstructured":"Stockfelt M, Teng YKO, Vital EM. Opportunities and limitations of B cell depletion approaches in SLE. Nat Rev Rheumatol. 2025;21:111\u201326. https:\/\/doi.org\/10.1038\/s41584-024-01210-9.","journal-title":"Nat Rev Rheumatol"},{"key":"1397_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103648","volume":"23","author":"L Arnaud","year":"2024","unstructured":"Arnaud L, Chasset F, Martin T. Immunopathogenesis of systemic lupus erythematosus: an update. Autoimmun Rev. 2024;23:103648. https:\/\/doi.org\/10.1016\/j.autrev.2024.103648.","journal-title":"Autoimmun Rev"},{"key":"1397_CR17","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41584-024-01179-5","volume":"20","author":"T D\u00f6rner","year":"2024","unstructured":"D\u00f6rner T, Lipsky PE. The essential roles of memory B cells in the pathogenesis of systemic lupus erythematosus. Nat Rev Rheumatol. 2024;20:770\u201382. https:\/\/doi.org\/10.1038\/s41584-024-01179-5.","journal-title":"Nat Rev Rheumatol"},{"key":"1397_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-025-09021-w","volume":"68","author":"G Xie","year":"2025","unstructured":"Xie G, Chen X, Gao Y, Yang M, Zhou S, Lu L, et al. Age-associated B cells in autoimmune diseases: pathogenesis and clinical implications. Clin Rev Allergy Immunol. 2025;68:18. https:\/\/doi.org\/10.1007\/s12016-025-09021-w.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1397_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102870","volume":"132","author":"H Li","year":"2022","unstructured":"Li H, Boulougoura A, Endo Y, Tsokos GC. Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies. J Autoimmun. 2022;132:102870. https:\/\/doi.org\/10.1016\/j.jaut.2022.102870.","journal-title":"J Autoimmun"},{"key":"1397_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101981","volume":"89","author":"W Li","year":"2023","unstructured":"Li W, Yu L, Li W, Ge G, Ma Y, Xiao L, et al. Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: underlying mechanisms based on cell and molecular targets. Ageing Res Rev. 2023;89:101981. https:\/\/doi.org\/10.1016\/j.arr.2023.101981.","journal-title":"Ageing Res Rev"},{"key":"1397_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01027","volume":"11","author":"J Shan","year":"2020","unstructured":"Shan J, Jin H, Xu Y. T cell metabolism: a new perspective on Th17\/Treg cell imbalance in systemic lupus erythematosus. Front Immunol. 2020;11:1027. https:\/\/doi.org\/10.3389\/fimmu.2020.01027.","journal-title":"Front Immunol"},{"key":"1397_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1305590","volume":"14","author":"Y-Y Tang","year":"2023","unstructured":"Tang Y-Y, Wang D-C, Chen Y-Y, Xu W-D, Huang A-F. Th1-related transcription factors and cytokines in systemic lupus erythematosus. Front Immunol. 2023;14:1305590. https:\/\/doi.org\/10.3389\/fimmu.2023.1305590.","journal-title":"Front Immunol"},{"key":"1397_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2022.103213","volume":"22","author":"H Wang","year":"2023","unstructured":"Wang H, Li C, Ren G, Yang C, Sun J. Updated insight into the role of Th2-associated immunity in systemic lupus erythematosus. Autoimmun Rev. 2023;22:103213. https:\/\/doi.org\/10.1016\/j.autrev.2022.103213.","journal-title":"Autoimmun Rev"},{"key":"1397_CR24","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.159751","volume":"7","author":"N Richoz","year":"2022","unstructured":"Richoz N, Tuong ZK, Loudon KW, Pati\u00f1o-Mart\u00ednez E, Ferdinand JR, Portet A, et al. Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis. JCI Insight. 2022;7:e159751. https:\/\/doi.org\/10.1172\/jci.insight.159751.","journal-title":"JCI Insight"},{"key":"1397_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2023.110305","volume":"120","author":"X He","year":"2023","unstructured":"He X, Jiang L, Hu L, Du P, Zhu M, Wu H, et al. Mivebresib alleviates systemic lupus erythematosus-associated diffuse alveolar hemorrhage via inhibiting infiltration of monocytes and M1 polarization of macrophages. Int Immunopharmacol. 2023;120:110305. https:\/\/doi.org\/10.1016\/j.intimp.2023.110305.","journal-title":"Int Immunopharmacol"},{"key":"1397_CR26","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03437-4","volume":"23","author":"J Ji","year":"2025","unstructured":"Ji J, Yang S, Xu Y, He Q, Liang Q, Feng G, et al. M2-ApoBDs as a therapeutic strategy for systemic lupus erythematosus: targeted macrophage reprogramming and treg differentiation. J Nanobiotechnol. 2025;23:354. https:\/\/doi.org\/10.1186\/s12951-025-03437-4.","journal-title":"J Nanobiotechnol"},{"key":"1397_CR27","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.kint.2023.03.030","volume":"104","author":"EJ Yoo","year":"2023","unstructured":"Yoo EJ, Oh K-H, Piao H, Kang HJ, Jeong GW, Park H, et al. Macrophage transcription factor TonEBP promotes systemic lupus erythematosus and kidney injury via damage-induced signaling pathways. Kidney Int. 2023;104:163\u201380. https:\/\/doi.org\/10.1016\/j.kint.2023.03.030.","journal-title":"Kidney Int"},{"key":"1397_CR28","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood C, Blanco LP, Purmalek MM, Carmona-Rivera C, De Ravin SS, Smith CK, et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat Med. 2016;22:146\u201353. https:\/\/doi.org\/10.1038\/nm.4027.","journal-title":"Nat Med"},{"key":"1397_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s12016-020-08804-7","volume":"61","author":"V Mutua","year":"2021","unstructured":"Mutua V, Gershwin LJ. A review of neutrophil extracellular traps (NETs) in disease: potential Anti-NETs therapeutics. Clin Rev Allergy Immunol. 2021;61:194\u2013211. https:\/\/doi.org\/10.1007\/s12016-020-08804-7.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1397_CR30","doi-asserted-by":"publisher","first-page":"2587","DOI":"10.1038\/s41401-025-01554-2","volume":"46","author":"Y Liang","year":"2025","unstructured":"Liang Y, Chen L, Huang Q, Song Y, Fan Y, Chen T, et al. Immune cells in systemic lupus erythematosus: biology and traditional Chinese medicine therapy. Acta Pharmacol Sin. 2025;46:2587\u201396. https:\/\/doi.org\/10.1038\/s41401-025-01554-2.","journal-title":"Acta Pharmacol Sin"},{"issue":"Suppl 1","key":"1397_CR31","doi-asserted-by":"publisher","first-page":"i22","DOI":"10.1093\/rheumatology\/keac678","volume":"62","author":"J He","year":"2023","unstructured":"He J, Li Z. Dilemma of immunosuppression and infection risk in systemic lupus erythematosus. Rheumatology (Oxford). 2023;62(Suppl 1):i22\u20139. https:\/\/doi.org\/10.1093\/rheumatology\/keac678.","journal-title":"Rheumatology (Oxford)"},{"key":"1397_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001266","volume":"11","author":"T Eviatar","year":"2024","unstructured":"Eviatar T, Yahalom R, Livnat I, Elboim M, Elkayam O, Chodick G, et al. Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage. Lupus Sci Med. 2024;11:e001266. https:\/\/doi.org\/10.1136\/lupus-2024-001266.","journal-title":"Lupus Sci Med"},{"key":"1397_CR33","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.1016\/S0140-6736(19)30237-5","volume":"393","author":"L Durcan","year":"2019","unstructured":"Durcan L, O\u2019Dwyer T, Petri M. Management strategies and future directions for systemic lupus erythematosus in adults. Lancet. 2019;393:2332\u201343. https:\/\/doi.org\/10.1016\/S0140-6736(19)30237-5.","journal-title":"Lancet"},{"key":"1397_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaut.2018.11.001","volume":"96","author":"A Fava","year":"2019","unstructured":"Fava A, Petri M. Systemic lupus erythematosus: diagnosis and clinical management. J Autoimmun. 2019;96:1\u201313. https:\/\/doi.org\/10.1016\/j.jaut.2018.11.001.","journal-title":"J Autoimmun"},{"key":"1397_CR35","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","volume":"377","author":"SV Navarra","year":"2011","unstructured":"Navarra SV, Guzm\u00e1n RM, Gallacher AE, Hall S, Levy RA, Jimenez RE, et al. Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377:721\u201331. https:\/\/doi.org\/10.1016\/S0140-6736(10)61354-2.","journal-title":"Lancet"},{"key":"1397_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","volume":"382","author":"EF Morand","year":"2020","unstructured":"Morand EF, Furie R, Tanaka Y, Bruce IN, Askanase AD, Richez C, et al. Trial of Anifrolumab in active systemic lupus erythematosus. N Engl J Med. 2020;382:211\u201321. https:\/\/doi.org\/10.1056\/NEJMoa1912196.","journal-title":"N Engl J Med"},{"key":"1397_CR37","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2509522","author":"Q Wang","year":"2025","unstructured":"Wang Q, Xiao ZX, Zheng X, Wang G, Yang L, Shi L, et al. In vivo CD19 CAR T-Cell therapy for refractory systemic lupus erythematosus. N Engl J Med. 2025. https:\/\/doi.org\/10.1056\/NEJMc2509522.","journal-title":"N Engl J Med"},{"key":"1397_CR38","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","volume":"28","author":"A Mackensen","year":"2022","unstructured":"Mackensen A, M\u00fcller F, Mougiakakos D, B\u00f6ltz S, Wilhelm A, Aigner M, et al. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus. Nat Med. 2022;28:2124\u201332. https:\/\/doi.org\/10.1038\/s41591-022-02017-5.","journal-title":"Nat Med"},{"issue":"Pt 2","key":"1397_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118884","volume":"337","author":"Y Li","year":"2025","unstructured":"Li Y, Duan Q, Wang C, Du L, Jiang Z, Li S, et al. Jieduquyuziyin prescription alleviates lupus development via inhibiting neddylation pathway to promote Bim-induced apoptosis of double negative T cells. J Ethnopharmacol. 2025;337(Pt 2):118884. https:\/\/doi.org\/10.1016\/j.jep.2024.118884.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116283","volume":"309","author":"Y He","year":"2023","unstructured":"He Y, Tian W, Zhang M, Qiu H, Li H, Shi X, et al. Jieduquyuziyin prescription alleviates SLE complicated by atherosclerosis via promoting cholesterol efflux and suppressing TLR9\/MyD88 activation. J Ethnopharmacol. 2023;309:116283. https:\/\/doi.org\/10.1016\/j.jep.2023.116283.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119914","volume":"349","author":"L Chen","year":"2025","unstructured":"Chen L, Fang T, Yao X, Zhao T, Lu D, Wang X. Jieduquyuziyin prescription suppresses the activation of the extrafollicular effector B cell by regulating integrin \u03b1V signaling in systemic lupus erythematosus. J Ethnopharmacol. 2025;349:119914. https:\/\/doi.org\/10.1016\/j.jep.2025.119914.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2025.149628","volume":"964","author":"R Li","year":"2025","unstructured":"Li R, Liu J, Gan Y, Jin M, Lin K, Wu Y, et al. Identification of lipid metabolism-associated biomarkers in lupus nephritis by SVM model and therapeutic potential of Alisol B 23-acetate. Gene. 2025;964:149628. https:\/\/doi.org\/10.1016\/j.gene.2025.149628.","journal-title":"Gene"},{"key":"1397_CR43","doi-asserted-by":"publisher","first-page":"10020","DOI":"10.1039\/d4fo02773f","volume":"15","author":"J Liu","year":"2024","unstructured":"Liu J, Wang N, Wu Z, Gan Y, Ji J, Huang Z, et al. Apigenin ameliorates lupus nephritis by inhibiting SAT3 signaling in CD8+ T cells. Food Funct. 2024;15:10020\u201336. https:\/\/doi.org\/10.1039\/d4fo02773f.","journal-title":"Food Funct"},{"key":"1397_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.175823","volume":"953","author":"T Ding","year":"2023","unstructured":"Ding T, Yi T, Li Y, Zhang W, Wang X, Liu J, et al. Luteolin attenuates lupus nephritis by regulating macrophage oxidative stress via HIF-1\u03b1 pathway. Eur J Pharmacol. 2023;953:175823. https:\/\/doi.org\/10.1016\/j.ejphar.2023.175823.","journal-title":"Eur J Pharmacol"},{"key":"1397_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.117602","volume":"323","author":"D Li","year":"2024","unstructured":"Li D, Pan B, Ma N, Wang X, Deng X, Lai H, et al. Efficacy and safety of Shenqi Dihuang decoction for lupus nephritis: a systematic review and meta-analysis. J Ethnopharmacol. 2024;323:117602. https:\/\/doi.org\/10.1016\/j.jep.2023.117602.","journal-title":"J Ethnopharmacol"},{"issue":"04","key":"1397_CR46","doi-asserted-by":"publisher","first-page":"176","DOI":"10.13193\/j.issn.1673-7717.2021.04.045","volume":"39","author":"K Yang","year":"2021","unstructured":"Yang K, Wang X, Gao X, He Z, Wang W, Zhang J. Effect and mechanism of Jiedu Quyu Ziyin prescription on lupus activity in patients with systemic lupus erythematosus. Chin Arch Tradit Chin Med. 2021;39(04):176\u20139. https:\/\/doi.org\/10.13193\/j.issn.1673-7717.2021.04.045.","journal-title":"Chin Arch Tradit Chin Med"},{"key":"1397_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18711","volume":"9","author":"A Lin","year":"2023","unstructured":"Lin A, Zhang Z, Liu X, Wu J. Oral proprietary Chinese medicine for lupus nephritis: a bayesian network meta-analysis. Heliyon. 2023;9:e18711. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18711.","journal-title":"Heliyon"},{"key":"1397_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2023.1185809","volume":"14","author":"W Wang","year":"2023","unstructured":"Wang W, Wang Y-H, Yang K, Ye X, Wang X, Wei JC-C. Traditional Chinese medicine use is associated with lower risk of pneumonia in patients with systemic lupus erythematosus: a population-based retrospective cohort study. Front Pharmacol. 2023;14:1185809. https:\/\/doi.org\/10.3389\/fphar.2023.1185809.","journal-title":"Front Pharmacol"},{"key":"1397_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2019.107452","volume":"207","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wei W. Anti-inflammatory and immunoregulatory effects of paeoniflorin and total glucosides of paeony. Pharmacol Ther. 2020;207:107452. https:\/\/doi.org\/10.1016\/j.pharmthera.2019.107452.","journal-title":"Pharmacol Ther"},{"key":"1397_CR50","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.joim.2020.08.007","volume":"18","author":"L Dai","year":"2020","unstructured":"Dai L, Chan KK, Mao J, Tian Y, Gu J, Zhou J, et al. Modified Zhibai Dihuang pill, a traditional Chinese medicine formula, on steroid withdrawal in systemic lupus erythematosus: a systematic review and meta-analysis. J Integr Med. 2020;18:478\u201391. https:\/\/doi.org\/10.1016\/j.joim.2020.08.007.","journal-title":"J Integr Med"},{"key":"1397_CR51","unstructured":"Wang X, Wen C, Fan Y. The clinic study of Jieduquyuziyin methods on theraping corticosteroid hyperlipemia in systemic lupus erythematosus. Zhejiang J Chin West Med. 2003;10\u20132.CNKI:SUN:ZJZH.0.2003\u201306\u2013003."},{"key":"1397_CR52","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.896476","volume":"13","author":"L Zeng","year":"2022","unstructured":"Zeng L, Yang T, Yang K, Yu G, Li J, Xiang W, et al. Curcumin and Curcuma longa extract in the treatment of 10 types of autoimmune diseases: a systematic review and meta-analysis of 31 randomized controlled trials. Front Immunol. 2022;13:896476. https:\/\/doi.org\/10.3389\/fimmu.2022.896476.","journal-title":"Front Immunol"},{"key":"1397_CR53","first-page":"886","volume":"49","author":"Y Jiang","year":"2020","unstructured":"Jiang Y, Zhang Q, Wang H, Tang D, Zhang Y, Yimo, et al. Expressions of IFN-\u03b3 and IL-4 before and after treatment of lupus nephritis with traditional Chinese medicine combined with cyclophosphamide and their values for efficacy prediction and evaluation. Iran J Public Health. 2020;49:886\u201395.","journal-title":"Iran J Public Health"},{"key":"1397_CR54","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.kjms.2011.03.001","volume":"27","author":"Y Liao","year":"2011","unstructured":"Liao Y, Liu C, Tsai T, Hung Y, Chang S, Lin H, et al. Preliminary study of a traditional Chinese medicine formula in systemic lupus erythematosus patients to taper steroid dose and prevent disease flare\u2010up. Kaohsiung J Med Sci. 2011;27:251\u20137. https:\/\/doi.org\/10.1016\/j.kjms.2011.03.001.","journal-title":"Kaohsiung J Med Sci"},{"key":"1397_CR55","first-page":"1446","volume":"15","author":"F Ye","year":"2023","unstructured":"Ye F, Guo F, Huang Y, Wang S. Study of peripheral blood inflammatory factor levels and their clinical value in patients with lupus nephritis. Am J Transl Res. 2023;15:1446\u201351.","journal-title":"Am J Transl Res"},{"key":"1397_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11655-011-0637-y","volume":"17","author":"W Wang","year":"2011","unstructured":"Wang W, Yu J, Tao X. Systemic lupus erythematosus complicated with femoral head ischemic necrosis treated by Chinese medicine therapy for activating blood and dredging collaterals method. Chin J Integr Med. 2011;17:105\u201310. https:\/\/doi.org\/10.1007\/s11655-011-0637-y.","journal-title":"Chin J Integr Med"},{"key":"1397_CR57","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032029","volume":"101","author":"M Wang","year":"2022","unstructured":"Wang M, Wang Z, Liu Y, Wang L, Wang X, Jiang P. The effectiveness and safety of total glucosides of paeony in systemic lupus erythematosus: a systematic review and meta-analysis. Medicine (Baltimore). 2022;101:e32029. https:\/\/doi.org\/10.1097\/MD.0000000000032029.","journal-title":"Medicine (Baltimore)"},{"key":"1397_CR58","doi-asserted-by":"publisher","first-page":"11391","DOI":"10.12998\/wjcc.v10.i31.11391","volume":"10","author":"T-T Cao","year":"2022","unstructured":"Cao T-T, Chen L, Zhen X-F, Zhao G-J, Zhang H-F, Hu Y. Dan Bai Xiao formula combined with glucocorticoids and cyclophosphamide for pediatric lupus nephritis: a pilot prospective study. World J Clin Cases. 2022;10:11391\u2013402. https:\/\/doi.org\/10.12998\/wjcc.v10.i31.11391.","journal-title":"World J Clin Cases"},{"key":"1397_CR59","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11655-007-0180-z","volume":"13","author":"C Wen","year":"2007","unstructured":"Wen C, Fan Y, Wang X, Li X, Lu K. Effect of detoxification, removing stasis and nourishing yin method on corticosteroid-induced hyperlipidemia in patients with systemic lupus erythematosus. Chin J Integr Med. 2007;13:180\u20134. https:\/\/doi.org\/10.1007\/s11655-007-0180-z.","journal-title":"Chin J Integr Med"},{"key":"1397_CR60","first-page":"3222","volume":"13","author":"Y Dai","year":"2021","unstructured":"Dai Y, Zhao M, Qiu F, Yan X, Fan Y, Sun C. Investigation of the effect of Huaiqihuang granules via adjuvant treatment in children with relapsed systemic lupus erythematosus. Am J Transl Res. 2021;13:3222\u20139.","journal-title":"Am J Transl Res"},{"key":"1397_CR61","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s11655-008-0180-7","volume":"14","author":"X Tao","year":"2008","unstructured":"Tao X, Zheng H, Yu J, Ma J, Zhang W. Regulatory effect of Langchuang serial recipes on T-lymphocyte subsets Th and Tc in patients with systemic lupus erythematosus. Chin J Integr Med. 2008;14:180\u20134. https:\/\/doi.org\/10.1007\/s11655-008-0180-7.","journal-title":"Chin J Integr Med"},{"key":"1397_CR62","doi-asserted-by":"publisher","unstructured":"Wen C,  Fan Y, Li X, LU K. Investigation on the effect of traditional Chinese medical Jieduquyuziyin methods on the quality of life with systemic lupus erythematosus. Chin Arch Trad Chin Med. 2007;1599\u2013602. https:\/\/doi.org\/10.3969\/j.issn.1673-7717.2007.08.027.","DOI":"10.3969\/j.issn.1673-7717.2007.08.027"},{"key":"1397_CR63","doi-asserted-by":"publisher","unstructured":"Wen C, Fan Y, Chen X, Tang X, Ge P, Wang X, et al. Study on the adjustable effect of Jiedu Quyu Ziyin recipe on the expression of fas in T lymphocyte subsets in systemic lupus erythematosus. Chin J Integr Tradit Western Nephrol. 2003;703\u2013805. https:\/\/doi.org\/10.3969\/j.issn.1009-587X.2003.12.009.","DOI":"10.3969\/j.issn.1009-587X.2003.12.009"},{"key":"1397_CR64","doi-asserted-by":"publisher","unstructured":"Wen C, Fan Y, Tang X, Gu H, Wang X, Li X, et al. Adjust effect of Jiedu Quyu Ziyin recipe on the level of sex hormones in systemic lupus erythematosus patients. Chinese J Integr Trad Western Nephrol. 2003;580\u20132. https:\/\/doi.org\/10.3969\/j.issn.1009-587X.2003.10.009.","DOI":"10.3969\/j.issn.1009-587X.2003.10.009"},{"key":"1397_CR65","doi-asserted-by":"publisher","DOI":"10.13288\/j.11-2166\/r.2005.05.017","author":"G Wu","year":"2005","unstructured":"Wu G, Fan Y. The influence of Jieduquyuziyin prescription on disease activity in patients with systemic lupus erythematosus. J Tradit Chin Med. 2005. https:\/\/doi.org\/10.13288\/j.11-2166\/r.2005.05.017.","journal-title":"J Tradit Chin Med"},{"key":"1397_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102615","volume":"119","author":"A Thanou","year":"2021","unstructured":"Thanou A, Jupe E, Purushothaman M, Niewold TB, Munroe ME. Clinical disease activity and flare in SLE: current concepts and novel biomarkers. J Autoimmun. 2021;119:102615. https:\/\/doi.org\/10.1016\/j.jaut.2021.102615.","journal-title":"J Autoimmun"},{"key":"1397_CR67","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.autrev.2018.10.005","volume":"18","author":"E Toubi","year":"2019","unstructured":"Toubi E, Vadasz Z. Innate immune-responses and their role in driving autoimmunity. Autoimmun Rev. 2019;18:306\u201311. https:\/\/doi.org\/10.1016\/j.autrev.2018.10.005.","journal-title":"Autoimmun Rev"},{"key":"1397_CR68","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1002\/art.38410","volume":"66","author":"R Sahu","year":"2014","unstructured":"Sahu R, Bethunaickan R, Singh S, Davidson A. Structure and function of renal macrophages and dendritic cells from lupus-prone mice. Arthritis Rheumatol. 2014;66:1596\u2013607. https:\/\/doi.org\/10.1002\/art.38410.","journal-title":"Arthritis Rheumatol"},{"key":"1397_CR69","doi-asserted-by":"publisher","first-page":"2357217","DOI":"10.1155\/2019\/2357217","volume":"2019","author":"L Ji","year":"2019","unstructured":"Ji L, Hou X, Deng X, Fan X, Zhuang A, Zhang X, et al. Jieduquyuziyin prescription-treated rat serum suppresses activation of peritoneal macrophages in MRL\/Lpr lupus mice by inhibiting IRAK1 signaling pathway. Evid Based Complement Alternat Med. 2019;2019:2357217. https:\/\/doi.org\/10.1155\/2019\/2357217.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1397_CR70","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.01049","volume":"11","author":"L Ji","year":"2020","unstructured":"Ji L, Fan X, Hou X, Fu D, Bao J, Zhuang A, et al. Jieduquyuziyin prescription suppresses inflammatory activity of MRL\/lpr mice and their bone marrow-derived macrophages via inhibiting expression of IRAK1-NF-\u03baB signaling pathway. Front Pharmacol. 2020;11:1049. https:\/\/doi.org\/10.3389\/fphar.2020.01049.","journal-title":"Front Pharmacol"},{"key":"1397_CR71","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2024.118545","volume":"334","author":"W Tian","year":"2024","unstructured":"Tian W, Qiu H, He Y, Zhang M, Pan X, Wang Y, et al. Qinghao-Biejia herb pair attenuates SLE atherosclerosis by regulating macrophage polarization via ABCA1\/G1-mediated cholesterol efflux. J Ethnopharmacol. 2024;334:118545. https:\/\/doi.org\/10.1016\/j.jep.2024.118545.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01709-9","volume":"9","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Du L, Wang C, Jiang Z, Duan Q, Li Y, et al. Neddylation is a novel therapeutic target for lupus by regulating double negative t cell homeostasis. Signal Transduct Target Ther. 2024;9:18. https:\/\/doi.org\/10.1038\/s41392-023-01709-9.","journal-title":"Signal Transduct Target Ther"},{"key":"1397_CR73","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119584","volume":"345","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Han Y, Li X, Huang S, Zhao K, Xie Z, et al. Study on the mechanism of Jieduquyuziyin prescription improving the condition of MRL\/lpr mice by regulating t cell metabolic reprogramming through the AMPK\/mTOR pathway. J Ethnopharmacol. 2025;345:119584. https:\/\/doi.org\/10.1016\/j.jep.2025.119584.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR74","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.jaut.2015.05.003","volume":"61","author":"P Coit","year":"2015","unstructured":"Coit P, Renauer P, Jeffries MA, Merrill JT, McCune WJ, Maksimowicz-McKinnon K, et al. Renal involvement in lupus is characterized by unique DNA methylation changes in na\u00efve CD4+ t cells. J Autoimmun. 2015;61:29\u201335. https:\/\/doi.org\/10.1016\/j.jaut.2015.05.003.","journal-title":"J Autoimmun"},{"key":"1397_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116776","volume":"317","author":"S Huang","year":"2023","unstructured":"Huang S, Peng J, Gan Y, Chen L, Zhu Z, Tian F, et al. Jieduquyuziyin prescription enhances CD11a and CD70 DNA methylation of CD4+ t cells via miR-29b-sp1\/DNMT1 pathway in MRL\/lpr mice. J Ethnopharmacol. 2023;317:116776. https:\/\/doi.org\/10.1016\/j.jep.2023.116776.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR76","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s11626-018-0295-x","volume":"54","author":"R Li","year":"2018","unstructured":"Li R, Zhuang A, Ma J, Ji L, Hou X, Chen H, et al. Effect of Jieduquyuziyin prescription-treated rat serum on MeCP2 gene expression in Jurkat T cells. In Vitro Cell Dev Biol Anim. 2018;54:692\u2013704. https:\/\/doi.org\/10.1007\/s11626-018-0295-x.","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"1397_CR77","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1146\/annurev-immunol-101921-042422","volume":"41","author":"S Caielli","year":"2023","unstructured":"Caielli S, Wan Z, Pascual V. Systemic lupus erythematosus pathogenesis: interferon and beyond. Annu Rev Immunol. 2023;41:533\u201360. https:\/\/doi.org\/10.1146\/annurev-immunol-101921-042422.","journal-title":"Annu Rev Immunol"},{"key":"1397_CR78","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.immuni.2018.08.015","volume":"49","author":"SA Jenks","year":"2018","unstructured":"Jenks SA, Cashman KS, Zumaquero E, Marigorta UM, Patel AV, Wang X, et al. Distinct effector B cells induced by unregulated toll-like receptor 7 contribute to pathogenic responses in systemic lupus erythematosus. Immunity. 2018;49:725-739.e6. https:\/\/doi.org\/10.1016\/j.immuni.2018.08.015.","journal-title":"Immunity"},{"key":"1397_CR79","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116625","volume":"315","author":"Y Gao","year":"2023","unstructured":"Gao Y, Zhou J, Huang Y, Wang M, Zhang Y, Zhang F, et al. Jiedu-Quyu-Ziyin Fang (JQZF) inhibits the proliferation and activation of B cells in MRL\/lpr mice via modulating the AKT\/mTOR\/c-Myc signaling pathway. J Ethnopharmacol. 2023;315:116625. https:\/\/doi.org\/10.1016\/j.jep.2023.116625.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR80","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.119626","volume":"345","author":"X Li","year":"2025","unstructured":"Li X, Zhu Q, Yang Z, Zhu M, Xie Z, Fan Y, et al. The Jieduquyuziyin prescription alleviates systemic lupus erythematosus by modulating B cell metabolic reprogramming via the AMPK\/PKM2 signaling pathway. J Ethnopharmacol. 2025;345:119626. https:\/\/doi.org\/10.1016\/j.jep.2025.119626.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR81","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1038\/s41590-019-0466-2","volume":"20","author":"FJ Barrat","year":"2019","unstructured":"Barrat FJ, Crow MK, Ivashkiv LB. Interferon target-gene expression and epigenomic signatures in health and disease. Nat Immunol. 2019;20:1574\u201383. https:\/\/doi.org\/10.1038\/s41590-019-0466-2.","journal-title":"Nat Immunol"},{"key":"1397_CR82","doi-asserted-by":"publisher","first-page":"869","DOI":"10.2215\/CJN.0000000000000185","volume":"18","author":"C Zhang","year":"2023","unstructured":"Zhang C, Han X, Jin Y, Chen X, Gong C, Peng J, et al. Pathogenic gene spectrum and clinical implication in Chinese patients with lupus nephritis. Clin J Am Soc Nephrol. 2023;18:869\u201380. https:\/\/doi.org\/10.2215\/CJN.0000000000000185.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1397_CR83","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41584-020-00544-4","volume":"17","author":"S Fillatreau","year":"2021","unstructured":"Fillatreau S, Manfroi B, D\u00f6rner T. Toll-like receptor signalling in B cells during systemic lupus erythematosus. Nat Rev Rheumatol. 2021;17:98\u2013108. https:\/\/doi.org\/10.1038\/s41584-020-00544-4.","journal-title":"Nat Rev Rheumatol"},{"key":"1397_CR84","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32752","volume":"10","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhang F, Zhang Y, Wang M, Gao Y, Li H, et al. Investigating the therapeutic mechanism of Jiedu-Quyu-Ziyin Fang on systemic lupus erythematosus through the ER\u03b1-miRNA-TLR7 immune axis. Heliyon. 2024;10:e32752. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32752.","journal-title":"Heliyon"},{"key":"1397_CR85","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4301033","volume":"2022","author":"J Liu","year":"2022","unstructured":"Liu J, Ma Q, Sun Q, Luo Q, Wang Y, Wang C, et al. Investigating the mechanisms of Jieduquyuziyin prescription improves lupus nephritis and fibrosis via FXR in MRL\/lpr mice. Oxid Med Cell Longev. 2022;2022:4301033. https:\/\/doi.org\/10.1155\/2022\/4301033.","journal-title":"Oxid Med Cell Longev"},{"key":"1397_CR86","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2017.144","volume":"49","author":"J-P Jhou","year":"2017","unstructured":"Jhou J-P, Chen S-J, Huang H-Y, Lin W-W, Huang D-Y, Tzeng S-J. Upregulation of Fc\u03b3RIIB by resveratrol via NF-\u03baB activation reduces B-cell numbers and ameliorates Lupus. Exp Mol Med. 2017;49:e381. https:\/\/doi.org\/10.1038\/emm.2017.144.","journal-title":"Exp Mol Med"},{"issue":"Suppl 3","key":"1397_CR87","doi-asserted-by":"publisher","first-page":"iii70","DOI":"10.1136\/ard.2008.098459","volume":"67","author":"T Weichhart","year":"2008","unstructured":"Weichhart T, S\u00e4emann MD. The PI3K\/Akt\/mTOR pathway in innate immune cells: emerging therapeutic applications. Ann Rheum Dis. 2008;67(Suppl 3):iii70-74. https:\/\/doi.org\/10.1136\/ard.2008.098459.","journal-title":"Ann Rheum Dis"},{"key":"1397_CR88","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2021.114815","volume":"284","author":"L Ji","year":"2022","unstructured":"Ji L, Wu S, Fu D, Fang S, Xie G, Fan Y, et al. Jieduquyuziyin prescription alleviates hepatic gluconeogenesis via PI3K\/Akt\/PGC-1\u03b1 pathway in glucocorticoid-induced MRL\/lpr mice. J Ethnopharmacol. 2022;284:114815. https:\/\/doi.org\/10.1016\/j.jep.2021.114815.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114607","volume":"154","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Ruan X, Zhou X, Li S, Wang C, Huang L, et al. Phlorizin attenuates lupus nephritis via upregulating PI3K\/Akt pathway-mediated Treg differentiation. Int Immunopharmacol. 2025;154:114607. https:\/\/doi.org\/10.1016\/j.intimp.2025.114607.","journal-title":"Int Immunopharmacol"},{"key":"1397_CR90","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2024-001220","volume":"11","author":"H Yang","year":"2024","unstructured":"Yang H, Zhang H, Tian L, Guo P, Liu S, Chen H, et al. Curcumin attenuates lupus nephritis by inhibiting neutrophil migration via PI3K\/AKT\/NF-\u03baB signalling pathway. Lupus Sci Med. 2024;11:e001220. https:\/\/doi.org\/10.1136\/lupus-2024-001220.","journal-title":"Lupus Sci Med"},{"key":"1397_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13101224","volume":"13","author":"L Liu","year":"2024","unstructured":"Liu L, de Leeuw K, van Goor H, Westra J. The role of antioxidant transcription factor Nrf2 and its activating compounds in systemic lupus erythematosus. Antioxidants (Basel). 2024;13:1224. https:\/\/doi.org\/10.3390\/antiox13101224.","journal-title":"Antioxidants (Basel)"},{"key":"1397_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24076053","volume":"24","author":"D-W Lin","year":"2023","unstructured":"Lin D-W, Hsu Y-C, Chang C-C, Hsieh C-C, Lin C-L. Insights into the molecular mechanisms of NRF2 in kidney injury and diseases. Int J Mol Sci. 2023;24:6053. https:\/\/doi.org\/10.3390\/ijms24076053.","journal-title":"Int J Mol Sci"},{"key":"1397_CR93","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115643","volume":"298","author":"L Du","year":"2022","unstructured":"Du L, Feng Y, Wang C, Shi X, Wen C, He Z, et al. Jieduquyuziyin prescription promotes the efficacy of Prednisone via upregulating Nrf2 in MRL\/lpr kidneys. J Ethnopharmacol. 2022;298:115643. https:\/\/doi.org\/10.1016\/j.jep.2022.115643.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115004","volume":"288","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Li Z, Wu H, Wang J, Zhang S. Esculetin alleviates murine Lupus Nephritis by inhibiting complement activation and enhancing Nrf2 signaling pathway. J Ethnopharmacol. 2022;288:115004. https:\/\/doi.org\/10.1016\/j.jep.2022.115004.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR95","doi-asserted-by":"publisher","first-page":"2006","DOI":"10.1093\/rheumatology\/kead547","volume":"63","author":"CE Rysenga","year":"2024","unstructured":"Rysenga CE, May-Zhang L, Zahavi M, Knight JS, Ali RA. Taxifolin inhibits NETosis through activation of Nrf2 and provides protective effects in models of lupus and antiphospholipid syndrome. Rheumatology (Oxford). 2024;63:2006\u201315. https:\/\/doi.org\/10.1093\/rheumatology\/kead547.","journal-title":"Rheumatology (Oxford)"},{"key":"1397_CR96","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2021-000611","volume":"9","author":"X-C Chen","year":"2022","unstructured":"Chen X-C, Wu D, Wu H-L, Li H-Y, Yang C, Su H-Y, et al. Metformin improves renal injury of MRL\/lpr Lupus-prone mice via the AMPK\/STAT3 pathway. Lupus Sci Med. 2022;9:e000611. https:\/\/doi.org\/10.1136\/lupus-2021-000611.","journal-title":"Lupus Sci Med"},{"key":"1397_CR97","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.intimp.2018.10.025","volume":"65","author":"X Peng","year":"2018","unstructured":"Peng X, Yang T, Liu G, Liu H, Peng Y, He L. Piperine ameliorated lupus nephritis by targeting AMPK-mediated activation of NLRP3 inflammasome. Int Immunopharmacol. 2018;65:448\u201357. https:\/\/doi.org\/10.1016\/j.intimp.2018.10.025.","journal-title":"Int Immunopharmacol"},{"key":"1397_CR98","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.4049\/jimmunol.1502581","volume":"197","author":"LE Padgett","year":"2016","unstructured":"Padgett LE, Tse HM. NADPH oxidase\u2013derived superoxide provides a third signal for CD4 T cell effector responses. J Immunol. 2016;197:1733\u201342. https:\/\/doi.org\/10.4049\/jimmunol.1502581.","journal-title":"J Immunol"},{"key":"1397_CR99","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41423-022-00840-x","volume":"19","author":"H Chi","year":"2022","unstructured":"Chi H. Immunometabolism at the intersection of metabolic signaling, cell fate, and systems immunology. Cell Mol Immunol. 2022;19:299\u2013302. https:\/\/doi.org\/10.1038\/s41423-022-00840-x.","journal-title":"Cell Mol Immunol"},{"key":"1397_CR100","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41584-025-01267-0","volume":"21","author":"E Pati\u00f1o-Martinez","year":"2025","unstructured":"Pati\u00f1o-Martinez E, Kaplan MJ. Immunometabolism in systemic lupus erythematosus | nature reviews rheumatology. Nat Rev Rheumatol. 2025;21:377\u201395. https:\/\/doi.org\/10.1038\/s41584-025-01267-0.","journal-title":"Nat Rev Rheumatol"},{"key":"1397_CR101","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","volume":"12","author":"A Davidson","year":"2016","unstructured":"Davidson A. What is damaging the kidney in lupus nephritis? Nat Rev Rheumatol. 2016;12:143\u201353. https:\/\/doi.org\/10.1038\/nrrheum.2015.159.","journal-title":"Nat Rev Rheumatol"},{"key":"1397_CR102","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12016-016-8533-z","volume":"52","author":"S Yung","year":"2017","unstructured":"Yung S, Chan TM. Molecular and immunological basis of tubulo-interstitial injury in lupus nephritis: a comprehensive review. Clin Rev Allergy Immunol. 2017;52:149\u201363. https:\/\/doi.org\/10.1007\/s12016-016-8533-z.","journal-title":"Clin Rev Allergy Immunol"},{"key":"1397_CR103","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4987323","volume":"2022","author":"S Wu","year":"2022","unstructured":"Wu S, Ji L, Fan X, Fang S, Bao J, Yuan X, et al. Jieduquyuzishen prescription attenuates renal fibrosis in MRL\/lpr mice via inhibiting EMT and TGF-\u03b21\/Smad2\/3 pathway. Evid Based Complement Alternat Med. 2022;2022:4987323. https:\/\/doi.org\/10.1155\/2022\/4987323.","journal-title":"Evid Based Complement Alternat Med"},{"key":"1397_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.155966","volume":"134","author":"P Shen","year":"2024","unstructured":"Shen P, Deng X, Chen Z, Chen M, Han L, Chen X, et al. Demethylzeylasteral ameliorates podocyte damage in murine lupus by inhibiting inflammation and enhancing autophagy. Phytomedicine. 2024;134:155966. https:\/\/doi.org\/10.1016\/j.phymed.2024.155966.","journal-title":"Phytomedicine"},{"key":"1397_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2023.116284","volume":"309","author":"L He","year":"2023","unstructured":"He L, Niu S, Yang C, Tang P, Fu J, Tan L, et al. Cordyceps proteins alleviate lupus nephritis through modulation of the STAT3\/mTOR\/NF-\u043aB signaling pathway. J Ethnopharmacol. 2023;309:116284. https:\/\/doi.org\/10.1016\/j.jep.2023.116284.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102890","volume":"132","author":"Y Xu","year":"2022","unstructured":"Xu Y, Li P, Li K, Li N, Liu H, Zhang X, et al. Pathological mechanisms and crosstalk among different forms of cell death in systemic lupus erythematosus. J Autoimmun. 2022;132:102890. https:\/\/doi.org\/10.1016\/j.jaut.2022.102890.","journal-title":"J Autoimmun"},{"key":"1397_CR107","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1177\/0961203309103152","volume":"18","author":"V Dhir","year":"2009","unstructured":"Dhir V, Singh A, Aggarwal A, Naik S, Misra R. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study. Lupus. 2009;18:785\u201391. https:\/\/doi.org\/10.1177\/0961203309103152.","journal-title":"Lupus"},{"key":"1397_CR108","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1136\/ard.58.5.309","volume":"58","author":"PA Courtney","year":"1999","unstructured":"Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis. 1999;58:309\u201314. https:\/\/doi.org\/10.1136\/ard.58.5.309.","journal-title":"Ann Rheum Dis"},{"key":"1397_CR109","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0039956","volume":"7","author":"M Bauer","year":"2012","unstructured":"Bauer M, Goldstein M, Heylmann D, Kaina B. Human monocytes undergo excessive apoptosis following Temozolomide activating the ATM\/ATR pathway while dendritic cells and macrophages are resistant. PLoS ONE. 2012;7:e39956. https:\/\/doi.org\/10.1371\/journal.pone.0039956.","journal-title":"PLoS ONE"},{"key":"1397_CR110","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1053\/j.ajkd.2006.05.019","volume":"48","author":"J Jeruc","year":"2006","unstructured":"Jeruc J, Vizjak A, Rozman B, Ferluga D. Immunohistochemical expression of activated Caspase-3 as a marker of apoptosis in glomeruli of human lupus nephritis. Am J Kidney Dis. 2006;48:410\u20138. https:\/\/doi.org\/10.1053\/j.ajkd.2006.05.019.","journal-title":"Am J Kidney Dis"},{"key":"1397_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2025.104996","volume":"414","author":"M Xu","year":"2025","unstructured":"Xu M, Li X, Bao C, Zhang Y, Yang J, Hang Y, et al. Curcumin mitigates systemic lupus erythematosus by suppressing double-negative T cells through cell apoptosis. Cell Immunol. 2025;414:104996. https:\/\/doi.org\/10.1016\/j.cellimm.2025.104996.","journal-title":"Cell Immunol"},{"key":"1397_CR112","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.4049\/jimmunol.2200508","volume":"209","author":"N Pandian","year":"2022","unstructured":"Pandian N, Kanneganti T-D. PANoptosis: a unique innate immune inflammatory cell death modality. J Immunol. 2022;209:1625\u201333.","journal-title":"J Immunol"},{"key":"1397_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2025.156996","volume":"145","author":"Y Wang","year":"2025","unstructured":"Wang Y, He Q-Q, Zhu Y-T, Zhang Y, Yan J, Liang L-F, et al. Total glucosides of paeony ameliorates lupus nephritis by suppressing ZBP1-mediated PANoptosis in podocytes. Phytomedicine. 2025;145:156996. https:\/\/doi.org\/10.1016\/j.phymed.2025.156996.","journal-title":"Phytomedicine"},{"key":"1397_CR114","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2023-001057","volume":"11","author":"T Xie","year":"2024","unstructured":"Xie T, Rui H, Liu H, Liu X, Liu X, Li P. Celastrol ameliorates Lupus by promoting apoptosis of autoimmune T cells and preventing autoimmune response in MRL\/lpr mice. Lupus Sci Med. 2024;11:e001057. https:\/\/doi.org\/10.1136\/lupus-2023-001057.","journal-title":"Lupus Sci Med"},{"key":"1397_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s12979-024-00474-9","volume":"21","author":"F Xiong","year":"2024","unstructured":"Xiong F, Shen K, Long D, Zhou S, Ruan P, Xin Y, et al. Quercetin ameliorates lupus symptoms by promoting the apoptosis of senescent Tfh cells via the Bcl-2 pathway. Immun Ageing. 2024;21:69. https:\/\/doi.org\/10.1186\/s12979-024-00474-9.","journal-title":"Immun Ageing"},{"key":"1397_CR116","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/s41577-021-00529-8","volume":"21","author":"K Voss","year":"2021","unstructured":"Voss K, Hong HS, Bader JE, Sugiura A, Lyssiotis CA, Rathmell JC. A guide to interrogating immunometabolism. Nat Rev Immunol. 2021;21:637\u201352. https:\/\/doi.org\/10.1038\/s41577-021-00529-8.","journal-title":"Nat Rev Immunol"},{"key":"1397_CR117","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1085\/jgp.8.6.519","volume":"8","author":"O Warburg","year":"1927","unstructured":"Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8:519\u201330. https:\/\/doi.org\/10.1085\/jgp.8.6.519.","journal-title":"J Gen Physiol"},{"key":"1397_CR118","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00833","volume":"10","author":"W Li","year":"2019","unstructured":"Li W, Qu G, Choi S-C, Cornaby C, Titov A, Kanda N, et al. Targeting T cell activation and Lupus autoimmune phenotypes by inhibiting glucose transporters. Front Immunol. 2019;10:833. https:\/\/doi.org\/10.3389\/fimmu.2019.00833.","journal-title":"Front Immunol"},{"key":"1397_CR119","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41584-019-0356-x","volume":"16","author":"A Sharabi","year":"2020","unstructured":"Sharabi A, Tsokos GC. T cell metabolism: new insights in systemic lupus erythematosus pathogenesis and therapy. Nat Rev Rheumatol. 2020;16:100\u201312. https:\/\/doi.org\/10.1038\/s41584-019-0356-x.","journal-title":"Nat Rev Rheumatol"},{"key":"1397_CR120","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1016\/j.jfma.2022.05.003","volume":"121","author":"H-J Liao","year":"2022","unstructured":"Liao H-J, Chu C-L, Wang S-C, Lee H-Y, Wu C-S. Increased HIF-1\u03b1 expression in T cells and associated with enhanced Th17 pathway in Systemic Lupus Erythematosus. J Formos Med Assoc. 2022;121:2446\u201356. https:\/\/doi.org\/10.1016\/j.jfma.2022.05.003.","journal-title":"J Formos Med Assoc"},{"key":"1397_CR121","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1002\/art.40785","volume":"71","author":"T Koga","year":"2019","unstructured":"Koga T, Sato T, Furukawa K, Morimoto S, Endo Y, Umeda M, et al. Promotion of calcium\/calmodulin-dependent protein kinase 4 by GLUT1-dependent glycolysis in systemic lupus erythematosus. Arth Rheumatol. 2019;71:766\u201372. https:\/\/doi.org\/10.1002\/art.40785.","journal-title":"Arth Rheumatol"},{"key":"1397_CR122","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","volume":"192","author":"A Caro-Maldonado","year":"2014","unstructured":"Caro-Maldonado A, Wang R, Nichols AG, Kuraoka M, Milasta S, Sun LD, et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J Immunol. 2014;192:3626\u201336. https:\/\/doi.org\/10.4049\/jimmunol.1302062.","journal-title":"J Immunol"},{"key":"1397_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-44540-0","volume":"15","author":"W Chi","year":"2024","unstructured":"Chi W, Kang N, Sheng L, Liu S, Tao L, Cao X, et al. MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation. Nat Commun. 2024;15:163. https:\/\/doi.org\/10.1038\/s41467-023-44540-0.","journal-title":"Nat Commun"},{"key":"1397_CR124","doi-asserted-by":"publisher","first-page":"425","DOI":"10.4049\/jimmunol.1601908","volume":"199","author":"M Torigoe","year":"2017","unstructured":"Torigoe M, Iwata S, Nakayamada S, Sakata K, Zhang M, Hajime M, et al. Metabolic reprogramming commits differentiation of human CD27+IgD+ B cells to plasmablasts or CD27-IgD-cells. J Immunol. 2017;199:425\u201334. https:\/\/doi.org\/10.4049\/jimmunol.1601908.","journal-title":"J Immunol"},{"key":"1397_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002084","volume":"21","author":"LP Blanco","year":"2023","unstructured":"Blanco LP, Kaplan MJ. Metabolic alterations of the immune system in the pathogenesis of autoimmune diseases. PLoS Biol. 2023;21:e3002084. https:\/\/doi.org\/10.1371\/journal.pbio.3002084.","journal-title":"PLoS Biol"},{"key":"1397_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-40900-3","volume":"9","author":"Y Becker","year":"2019","unstructured":"Becker Y, Loignon R-C, Julien A-S, Marcoux G, Allaeys I, L\u00e9vesque T, et al. Anti-mitochondrial autoantibodies in systemic lupus erythematosus and their association with disease manifestations. Sci Rep. 2019;9:4530. https:\/\/doi.org\/10.1038\/s41598-019-40900-3.","journal-title":"Sci Rep"},{"key":"1397_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120307","author":"R Chang","year":"2025","unstructured":"Chang R, Luo Y, Hu C, Xu X, Chen L, Wu J, et al. Jiedu Quyu Ziyin prescription alleviated renal injury in MRL\/lpr by inhibiting PPP-mediated oxidative stress through regulating p53\/G6PD\/NOX pathway. J Ethnopharmacol. 2025. https:\/\/doi.org\/10.1016\/j.jep.2025.120307.","journal-title":"J Ethnopharmacol"},{"key":"1397_CR128","doi-asserted-by":"publisher","DOI":"10.1016\/j.cbi.2024.110972","volume":"394","author":"T Yi","year":"2024","unstructured":"Yi T, Zhang W, Hua Y, Xin X, Wu Z, Li Y, et al. Rutin alleviates lupus nephritis by inhibiting T cell oxidative stress through PPAR\u03b3. Chem Biol Interact. 2024;394:110972. https:\/\/doi.org\/10.1016\/j.cbi.2024.110972.","journal-title":"Chem Biol Interact"},{"key":"1397_CR129","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1016\/j.semarthrit.2015.10.010","volume":"45","author":"K Tselios","year":"2016","unstructured":"Tselios K, Koumaras C, Gladman DD, Urowitz MB. Dyslipidemia in systemic lupus erythematosus: Just another comorbidity? Semin Arthritis Rheum. 2016;45:604\u201310. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.10.010.","journal-title":"Semin Arthritis Rheum"},{"key":"1397_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.860586","volume":"13","author":"W Sun","year":"2022","unstructured":"Sun W, Li P, Cai J, Ma J, Zhang X, Song Y, et al. Lipid metabolism: immune regulation and therapeutic prospectives in systemic lupus erythematosus. Front Immunol. 2022;13:860586. https:\/\/doi.org\/10.3389\/fimmu.2022.860586.","journal-title":"Front Immunol"},{"key":"1397_CR131","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.cmet.2023.03.010","volume":"35","author":"Q Zeng","year":"2023","unstructured":"Zeng Q, Wang S, Li M, Wang S, Guo C, Ruan X, et al. Spleen fibroblastic reticular cell-derived acetylcholine promotes lipid metabolism to drive autoreactive B cell responses. Cell Metab. 2023;35:837-854.e8. https:\/\/doi.org\/10.1016\/j.cmet.2023.03.010.","journal-title":"Cell Metab"},{"key":"1397_CR132","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114736","volume":"157","author":"Y Gan","year":"2025","unstructured":"Gan Y, Zhang Y, Liu J, Jin M, Lin K, Chen S, et al. Potential of CETP inhibition in treating dyslipidemia in systemic lupus erythematosus: novel and comprehensive evidence from clinical studies and Mendelian randomization. Int Immunopharmacol. 2025;157:114736. https:\/\/doi.org\/10.1016\/j.intimp.2025.114736.","journal-title":"Int Immunopharmacol"},{"key":"1397_CR133","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/biom15081078","volume":"15","author":"M Zhang","year":"2025","unstructured":"Zhang M, Pan X, He Y, Sun K, Wang Z, Tian W, et al. Artesunate ameliorates SLE atherosclerosis through PPAR\u03b3-driven cholesterol efflux restoration and disruption of lipid raft-organized TLR9\/MyD88 signaling pathway. Biomolecules. 2025;15:1078. https:\/\/doi.org\/10.3390\/biom15081078.","journal-title":"Biomolecules"},{"key":"1397_CR134","first-page":"3747","volume":"38","author":"J-B Hu","year":"2013","unstructured":"Hu J-B, Gu H-C, Ding Z-S, Yao L, Fan Y-S. Ding X-H [Study on intervention effect of Jieduquyuziyin prescription systemic lupus erythematosus by HPLC-Q-TOF\/MS]. Zhongguo Zhong Yao Za Zhi. 2013;38:3747\u201352.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"1397_CR135","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088223","volume":"9","author":"X Ding","year":"2014","unstructured":"Ding X, Hu J, Wen C, Ding Z, Yao L, Fan Y. Rapid Resolution liquid chromatography coupled with quadrupole time-of-flight mass spectrometry-based metabolomics approach to study the effects of Jieduquyuziyin prescription on systemic lupus erythematosus. PLoS ONE. 2014;9:e88223. https:\/\/doi.org\/10.1371\/journal.pone.0088223.","journal-title":"PLoS ONE"},{"key":"1397_CR136","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/s41575-023-00830-y","volume":"20","author":"R Bany Bakar","year":"2023","unstructured":"Bany Bakar R, Reimann F, Gribble FM. The intestine as an endocrine organ and the role of gut hormones in metabolic regulation. Nat Rev Gastroenterol Hepatol. 2023;20:784\u201396. https:\/\/doi.org\/10.1038\/s41575-023-00830-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"1397_CR137","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.626217","author":"F Liu","year":"2021","unstructured":"Liu F, Ren T, Li X, Zhai Q, Xu X, Zhang N, et al. Distinct microbiomes of gut and saliva in patients with systemic lupus erythematous and clinical associations. Front Immunol. 2021. https:\/\/doi.org\/10.3389\/fimmu.2021.626217.","journal-title":"Front Immunol"},{"key":"1397_CR138","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/art.41511","volume":"73","author":"B Chen","year":"2021","unstructured":"Chen B, Jia X, Xu J, Zhao L, Ji J, Wu B, et al. An autoimmunogenic and proinflammatory profile defined by the gut microbiota of patients with untreated systemic lupus erythematosus. Arth Rheumatol. 2021;73:232\u201343. https:\/\/doi.org\/10.1002\/art.41511.","journal-title":"Arth Rheumatol"},{"key":"1397_CR139","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1042\/CS20180841","volume":"133","author":"Y Li","year":"2019","unstructured":"Li Y, Wang H-F, Li X, Li H-X, Zhang Q, Zhou H-W, et al. Disordered intestinal microbes are associated with the activity of systemic lupus erythematosus. Clin Sci (Lond). 2019;133:821\u201338. https:\/\/doi.org\/10.1042\/CS20180841.","journal-title":"Clin Sci (Lond)"},{"key":"1397_CR140","doi-asserted-by":"publisher","first-page":"5206","DOI":"10.1038\/s41467-020-18871-1","volume":"11","author":"O Manor","year":"2020","unstructured":"Manor O, Dai CL, Kornilov SA, Smith B, Price ND, Lovejoy JC, et al. Health and disease markers correlate with gut microbiome composition across thousands of people. Nat Commun. 2020;11:5206. https:\/\/doi.org\/10.1038\/s41467-020-18871-1.","journal-title":"Nat Commun"},{"key":"1397_CR141","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.3390\/ijms20194871","volume":"20","author":"J-W Kim","year":"2019","unstructured":"Kim J-W, Kwok S-K, Choe J-Y, Park S-H. Recent advances in our understanding of the link between the intestinal microbiota and systemic lupus erythematosus. Int J Mol Sci. 2019;20:4871. https:\/\/doi.org\/10.3390\/ijms20194871.","journal-title":"Int J Mol Sci"},{"key":"1397_CR142","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s12016-025-09051-4","volume":"68","author":"L Jin","year":"2025","unstructured":"Jin L, Xiao J, Luo Y, Duan L, Gong Y, Li Y, et al. Exploring gut microbiota in systemic lupus erythematosus: insights and biomarker discovery potential. Clinic Rev Allerg Immunol. 2025;68:42. https:\/\/doi.org\/10.1007\/s12016-025-09051-4.","journal-title":"Clinic Rev Allerg Immunol"},{"key":"1397_CR143","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2021.717925","author":"T Vanuytsel","year":"2021","unstructured":"Vanuytsel T, Tack J, Farre R. The role of intestinal permeability in gastrointestinal disorders and current methods of evaluation. Front Nutr. 2021. https:\/\/doi.org\/10.3389\/fnut.2021.717925.","journal-title":"Front Nutr"},{"key":"1397_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1157813","author":"S Chen","year":"2023","unstructured":"Chen S, Lei Q, Zou X, Ma D. The role and mechanisms of gram-negative bacterial outer membrane vesicles in inflammatory diseases. Front Immunol. 2023. https:\/\/doi.org\/10.3389\/fimmu.2023.1157813.","journal-title":"Front Immunol"},{"key":"1397_CR145","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3945\/jn.110.135517","volume":"141","author":"SDK Kingma","year":"2011","unstructured":"Kingma SDK, Li N, Sun F, Valladares RB, Neu J, Lorca GL. Lactobacillus johnsonii N6.2 stimulates the innate immune response through toll-like receptor 9 in Caco-2 cells and increases intestinal crypt Paneth cell number in BioBreeding diabetes-prone rats. J Nutr. 2011;141:1023\u20138. https:\/\/doi.org\/10.3945\/jn.110.135517.","journal-title":"J Nutr"},{"key":"1397_CR146","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.jtcme.2024.05.005","volume":"15","author":"Z Zhu","year":"2024","unstructured":"Zhu Z, Wang M, Huang L, He Z. Jieduquyuziyin prescription attenuates the side effect of prednisone through regulating gut microbiota when in the combination with prednisone treat MRL\/lpr mice. J Tradit Complement Med. 2024;15:119\u201327. https:\/\/doi.org\/10.1016\/j.jtcme.2024.05.005.","journal-title":"J Tradit Complement Med"},{"key":"1397_CR147","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.00078-24","volume":"15","author":"J Gaifem","year":"2024","unstructured":"Gaifem J, Mendes-Frias A, Wolter M, Steimle A, Garz\u00f3n MJ, Ubeda C, et al. Akkermansia muciniphila and Parabacteroides distasonis synergistically protect from colitis by promoting ILC3 in the gut. MBio. 2024;15:e0007824. https:\/\/doi.org\/10.1128\/mbio.00078-24.","journal-title":"MBio"},{"key":"1397_CR148","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-0332-7","author":"D Z","year":"2020","unstructured":"Z D, L T, E E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020. https:\/\/doi.org\/10.1038\/s41422-020-0332-7.","journal-title":"Cell Res"},{"key":"1397_CR149","doi-asserted-by":"publisher","DOI":"10.3390\/foods11182863","volume":"11","author":"R-G Xiong","year":"2022","unstructured":"Xiong R-G, Zhou D-D, Wu S-X, Huang S-Y, Saimaiti A, Yang Z-J, et al. Health benefits and side effects of short-chain fatty acids. Foods. 2022;11:2863. https:\/\/doi.org\/10.3390\/foods11182863.","journal-title":"Foods"},{"key":"1397_CR150","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.ebiom.2018.03.030","volume":"30","author":"G Chen","year":"2018","unstructured":"Chen G, Ran X, Li B, Li Y, He D, Huang B, et al. Sodium butyrate inhibits inflammation and maintains epithelium barrier integrity in a TNBS-induced inflammatory bowel disease mice model. EBioMedicine. 2018;30:317\u201325. https:\/\/doi.org\/10.1016\/j.ebiom.2018.03.030.","journal-title":"EBioMedicine"},{"key":"1397_CR151","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186892","volume":"14","author":"X-F Liu","year":"2023","unstructured":"Liu X-F, Shao J-H, Liao Y-T, Wang L-N, Jia Y, Dong P-J, et al. Regulation of short-chain fatty acids in the immune system. Front Immunol. 2023;14:1186892. https:\/\/doi.org\/10.3389\/fimmu.2023.1186892.","journal-title":"Front Immunol"},{"key":"1397_CR152","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1126\/science.1241165","volume":"341","author":"PM Smith","year":"2013","unstructured":"Smith PM, Howitt MR, Panikov N, Michaud M, Gallini CA, Bohlooly-Y M, et al. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science. 2013;341:569\u201373. https:\/\/doi.org\/10.1126\/science.1241165.","journal-title":"Science"},{"key":"1397_CR153","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2023.106997","volume":"198","author":"J Mole\u00f3n","year":"2023","unstructured":"Mole\u00f3n J, Gonz\u00e1lez-Correa C, Mi\u00f1ano S, Robles-Vera I, de la Visitaci\u00f3n N, Barranco AM, et al. Protective effect of microbiota-derived short chain fatty acids on vascular dysfunction in mice with systemic lupus erythematosus induced by toll like receptor 7 activation. Pharmacol Res. 2023;198:106997. https:\/\/doi.org\/10.1016\/j.phrs.2023.106997.","journal-title":"Pharmacol Res"},{"key":"1397_CR154","doi-asserted-by":"publisher","DOI":"10.1016\/j.fbio.2024.103831","volume":"59","author":"X Liu","year":"2024","unstructured":"Liu X, Su S, Yao J, Zhang X, Wu Z, Jia L, et al. Research advance about plant polysaccharide prebiotics, benefit for probiotics on gut homeostasis modulation. Food Biosci. 2024;59:103831. https:\/\/doi.org\/10.1016\/j.fbio.2024.103831.","journal-title":"Food Biosci"},{"key":"1397_CR155","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/gutjnl-2017-315458","volume":"68","author":"T-R Wu","year":"2019","unstructured":"Wu T-R, Lin C-S, Chang C-J, Lin T-L, Martel J, Ko Y-F, et al. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut. 2019;68:248\u201362. https:\/\/doi.org\/10.1136\/gutjnl-2017-315458.","journal-title":"Gut"},{"key":"1397_CR156","doi-asserted-by":"publisher","DOI":"10.1016\/j.carbpol.2024.122829","volume":"349","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Ji W, Qin H, Chen Z, Zhou Y, Zhou Z, et al. Astragalus polysaccharides alleviate DSS-induced ulcerative colitis in mice by restoring SCFA production and regulating Th17\/Treg cell homeostasis in a microbiota-dependent manner. Carbohydr Polym. 2025;349:122829. https:\/\/doi.org\/10.1016\/j.carbpol.2024.122829.","journal-title":"Carbohydr Polym"},{"key":"1397_CR157","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2024.100754","volume":"48","author":"S-H Chang","year":"2025","unstructured":"Chang S-H, Ko Y-F, Liau J-C, Wu C-Y, Hwang T-L, Ojcius DM, et al. Hirsutella sinensis polysaccharides and Parabacteroides goldsteinii reduce lupus severity in imiquimod-treated mice. Biomed J. 2025;48:100754. https:\/\/doi.org\/10.1016\/j.bj.2024.100754.","journal-title":"Biomed J"},{"key":"1397_CR158","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1177\/0961203313501401","volume":"23","author":"SM Vieira","year":"2014","unstructured":"Vieira SM, Pagovich OE, Kriegel MA. Diet, microbiota and autoimmune diseases. Lupus. 2014;23:518\u201326. https:\/\/doi.org\/10.1177\/0961203313501401.","journal-title":"Lupus"},{"key":"1397_CR159","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2247053","volume":"15","author":"J Mole\u00f3n","year":"2023","unstructured":"Mole\u00f3n J, Gonz\u00e1lez-Correa C, Robles-Vera I, Mi\u00f1ano S, de la Visitaci\u00f3n N, Barranco AM, et al. Targeting the gut microbiota with dietary fibers: a novel approach to prevent the development cardiovascular complications linked to Systemic Lupus Erythematosus in a preclinical study. Gut Microbes. 2023;15:2247053. https:\/\/doi.org\/10.1080\/19490976.2023.2247053.","journal-title":"Gut Microbes"},{"key":"1397_CR160","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.cmet.2023.06.004","volume":"35","author":"C Xue","year":"2023","unstructured":"Xue C, Li G, Zheng Q, Gu X, Shi Q, Su Y, et al. Tryptophan metabolism in health and disease. Cell Metab. 2023;35:1304\u201326. https:\/\/doi.org\/10.1016\/j.cmet.2023.06.004.","journal-title":"Cell Metab"},{"key":"1397_CR161","doi-asserted-by":"publisher","DOI":"10.3390\/cells12050793","volume":"12","author":"J Wang","year":"2023","unstructured":"Wang J, Zhu N, Su X, Gao Y, Yang R. Gut-microbiota-derived metabolites maintain gut and systemic immune homeostasis. Cells. 2023;12:793. https:\/\/doi.org\/10.3390\/cells12050793.","journal-title":"Cells"},{"key":"1397_CR162","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105358","volume":"164","author":"W Jing","year":"2021","unstructured":"Jing W, Dong S, Luo X, Liu J, Wei B, Du W, et al. Berberine improves colitis by triggering AhR activation by microbial tryptophan catabolites. Pharmacol Res. 2021;164:105358. https:\/\/doi.org\/10.1016\/j.phrs.2020.105358.","journal-title":"Pharmacol Res"},{"key":"1397_CR163","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/jsfa.12242","volume":"103","author":"Y Chen","year":"2023","unstructured":"Chen Y, Hao Z, Zhao H, Duan X, Jia D, Li K, et al. Berberine alleviates intestinal barrier dysfunction in glucolipid metabolism disorder hamsters by modulating gut microbiota and gut-microbiota-related tryptophan metabolites. J Sci Food Agric. 2023;103:1464\u201373. https:\/\/doi.org\/10.1002\/jsfa.12242.","journal-title":"J Sci Food Agric"},{"key":"1397_CR164","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429249908231221080806","volume":"17","author":"AR Nikpoor","year":"2024","unstructured":"Nikpoor AR, Mahmoudi M, Shapouri-Moghaddam A, Rezaieyazdi Z, Mollazadeh S, Tabasi N, et al. Curcumin and berberine arrest maturation and activation of dendritic cells derived from Lupus Erythematosus patients. Curr Mol Pharmacol. 2024;17:e18761429249908. https:\/\/doi.org\/10.2174\/0118761429249908231221080806.","journal-title":"Curr Mol Pharmacol"},{"key":"1397_CR165","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins SL, Stine JG, Bisanz JE, Okafor CD, Patterson AD. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat Rev Microbiol. 2023;21:236\u201347. https:\/\/doi.org\/10.1038\/s41579-022-00805-x.","journal-title":"Nat Rev Microbiol"},{"key":"1397_CR166","doi-asserted-by":"publisher","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","volume":"318","author":"JYL Chiang","year":"2020","unstructured":"Chiang JYL, Ferrell JM. Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy. Am J Physiol Gastrointest Liver Physiol. 2020;318:G554\u201373. https:\/\/doi.org\/10.1152\/ajpgi.00223.2019.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"1397_CR167","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2021.154797","volume":"120","author":"S Huang","year":"2021","unstructured":"Huang S, Wu Y, Zhao Z, Wu B, Sun K, Wang H, et al. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophage. Metabolism. 2021;120:154797. https:\/\/doi.org\/10.1016\/j.metabol.2021.154797.","journal-title":"Metabolism"},{"key":"1397_CR168","doi-asserted-by":"publisher","DOI":"10.3390\/cells14120920","volume":"14","author":"H Jia","year":"2025","unstructured":"Jia H, He X, Jiang T, Kong F. Roles of bile acid-activated receptors in monocytes-macrophages and dendritic cells. Cells. 2025;14:920. https:\/\/doi.org\/10.3390\/cells14120920.","journal-title":"Cells"},{"key":"1397_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108238","volume":"237","author":"J Cai","year":"2022","unstructured":"Cai J, Rimal B, Jiang C, Chiang JYL, Patterson AD. Bile acid metabolism and signaling, the microbiota, and metabolic disease. Pharmacol Ther. 2022;237:108238. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108238.","journal-title":"Pharmacol Ther"},{"key":"1397_CR170","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/s41423-025-01309-3","volume":"22","author":"X Wang","year":"2025","unstructured":"Wang X, Ye L, Liu S, Zheng Y, Zhu L, Huang W, et al. FXR inhibition functions as a checkpoint blockade of the pathogenic Tfh cell response in lupus. Cell Mol Immunol. 2025;22:889\u2013900. https:\/\/doi.org\/10.1038\/s41423-025-01309-3.","journal-title":"Cell Mol Immunol"}],"container-title":["Chinese Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13020-026-01397-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13020-026-01397-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:14:11Z","timestamp":1776154451000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13020-026-01397-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1397"],"URL":"https:\/\/doi.org\/10.1186\/s13020-026-01397-x","relation":{},"ISSN":["1749-8546"],"issn-type":[{"value":"1749-8546","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"118"}}